Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT06055816 · RECRUITING
Trial details
- NCT number
- NCT06055816
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2024-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.